Certified by Founder Lodge
Parker Institute for Cancer Immunotherapy
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $75,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy b
| Company | Date | Round | Raised |
|---|---|---|---|
 Georgiamune Inc. |
August, 10 ,2023 | Series A | $75,000,000 |
Knit
CHARM Therapeutics
Curebase
SLAMcore Limited
Anthropic
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
